Wall Street's Insights Into Key Metrics Ahead of Amneal (AMRX) Q2 Earnings

Wall Street analysts forecast that Amneal Pharmaceuticals (AMRX) will report quarterly earnings of $0.14 per share in its upcoming release, pointing to a year-over-year decline of 26.3%. It is anticipated that revenues will amount to $657.43 million, exhibiting an increase of 9.8% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 4.4% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated t ...